Product

Shingrix

Shingles prevention vaccine

Procedure Information at a Glance

Quick overview of treatment time, anesthesia, recovery, and recommended interval. Key information to know before the procedure.

Recommended For

Learn whether this procedure suits your concerns. Check if it matches your situation.

Previous Shingles History Recommended even with previous shingles history, as recurrence is possible.

Adults Age 50+ Recommended starting at age 50, as shingles risk increases sharply with age.

Immunocompromised Persons Recommended for immunocompromised adults age 18+ (post-transplant, on chemotherapy, autoimmune treatment).

Why Choose This Procedure

Key benefits and expected results of this procedure.

Shingles Prevention Prevents shingles (herpes zoster) in adults age 50 and older. GSK recombinant vaccine.

Post-Herpetic Neuralgia Prevention Reduces the incidence of post-herpetic neuralgia (PHN), the most common complication of shingles.

Effective for Immunocompromised Vaccination is approved and effective for immunocompromised patients (e.g., post-stem cell transplant, chemotherapy).

Is This Right for Me?

Accurate diagnosis requires in-person consultation with our medical team. Schedule a consultation now.

What Makes This Procedure Special

Discover what makes Ineeclinic's approach to this procedure unique.

Core Principles

Learn how the procedure works and what technologies and devices are used.

Solutions Used in This Procedure

Devices, medications, and solutions used in this procedure.

Important Precautions

Pre- and post-procedure precautions. Review carefully for safe and effective results.

2-Dose Schedule (Shingrix)2 doses required. The 2nd dose must be given 2 to 6 months after the 1st dose for full protection.

Common Vaccination ReactionsFever, headache, muscle pain, and injection site pain commonly occur for 1-3 days after vaccination and resolve naturally.

Frequently Asked Questions

Frequently asked questions from our patients.

Shingrix is a recombinant protein vaccine. Unlike previous live vaccines (Zostavax), it is approved for immunocompromised persons and shows over 90% efficacy in adults age 50+.

2 doses required. The 2nd dose must be administered 2 to 6 months after the 1st dose. Long-term immunogenicity is established after completing 2 doses.

Evidence-Based Practice, Backed by Research

Academic publications supporting the efficacy and safety of this procedure.

Neck Rejuvenation with Calcium Hydroxylapatite, Hyaluronic Acid Filler, and IncobotulinumtoxinA: A Case Study Korean Association for Laser Dermatology and Trichology

ABCs in the Prevention of Filler-induced Ocular Complications Korean Association for Laser Dermatology and Trichology

Non-thermal, Non-equilibrium, Indirect, Jet Plasma Treatment with Nitrogen Gas As a Therapeutic Option for Acne Vulgaris: A Case Report of Clinical Experiences Korean Association for Laser Dermatology and Trichology

Pre-injection ultrasound scanning for treating temporal hollowing Journal of Cosmetic Dermatology

Retrospective Study of Horizontal Neckline Correction Using Absorbable Braided Polydioxanone Threads Korean Association for Laser Dermatology and Trichology

Sonoanatomy of the platysmal bands: What causes the platysmal band? Surgical and Radiologic Anatomy

Current practices and perceived effectiveness of polynucleotides for treatment of facial erythema by cosmetic physicians Skin Research

Atelocollagen Increases Collagen Synthesis by Promoting Glycine Transporter 1 in Aged Mouse Skin International Journal of Molecular Sciences

Find the Right Procedure for You

Explore other procedures that may interest you. We welcome personalized consultations anytime.